Trastuzumab biosimilar
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Trastuzumab biosimilar, covering 2025-03-18 to 2025-12-24. Get the full timeline:
Most recent: Clinical Trial Update: Real World Study of Biosimilar Trastuzumab in Her2 Positive Breast Cancer